Latest TMS Research

Daily left prefrontal rTMS as monotherapy produced statistically significant and clinically meaningful antidepressant therapeutic effects greater than sham.

We tested whether Transcranial Magnetic Stimulation (TMS) over the left dorsolateral prefrontal cortex (DLPFC) is effective and safe in the acute treatment of major depression. 

This report describes the results of an open-label extension study of active trans-cranial magnetic stimulation (TMS) in medication-resistant patients with major depressive disorder who did not benefit from an initial course of therapy in a previously reported 6-week, randomized controlled study of active versus sham TMS.

Repetitive transcranial magnetic stimulation (rTMS) is efficacious in treatment-resistant depression when applied with high-frequency stimulation (HF-rTMS: 5 Hz to 25 Hz) over the left dorsolateral prefrontal cortex (PFC) and with low-frequency stimulation (LF-rTMS≤1 Hz) over the right dorsolateral PFC.1 rTMS is known to be painless and well-tolerated, and does not require, as a rule, either premedication or special biological monitoring.

Non-supression of the post-dexamethasone cortisol is a feature of endogenous/melancholia depression.  Normalization of the dexathemasone supression test response is a feature of remission and antidepressant treatment...

1 / 1

Please reload

You May Also Be Interested In